Lv11
10 积分 2026-07-07 加入
Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study
6小时前
待确认
Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
7小时前
已完结
程序性死亡蛋白 1 抗体 SHR-1210 治疗晚期实体瘤患者中肾上腺皮质功能减退的临床报道
8小时前
已完结
皖公网安备34019202002308
